These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway. Zhao J; Fu Y; Liu CC; Shinohara M; Nielsen HM; Dong Q; Kanekiyo T; Bu G J Biol Chem; 2014 Apr; 289(16):11282-11292. PubMed ID: 24599963 [TBL] [Abstract][Full Text] [Related]
4. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS Acta Neuropathol Commun; 2014 Jan; 2():9. PubMed ID: 24456642 [TBL] [Abstract][Full Text] [Related]
5. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640 [TBL] [Abstract][Full Text] [Related]
6. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. Liang Y; Lin S; Beyer TP; Zhang Y; Wu X; Bales KR; DeMattos RB; May PC; Li SD; Jiang XC; Eacho PI; Cao G; Paul SM J Neurochem; 2004 Feb; 88(3):623-34. PubMed ID: 14720212 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro. Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324 [TBL] [Abstract][Full Text] [Related]
8. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284 [TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ε4 modulates astrocyte neuronal support functions in the presence of amyloid-β. Fleeman RM; Kuhn MK; Chan DC; Proctor EA J Neurochem; 2023 May; 165(4):536-549. PubMed ID: 36762973 [TBL] [Abstract][Full Text] [Related]
10. Quercetin stabilizes apolipoprotein E and reduces brain Aβ levels in amyloid model mice. Zhang X; Hu J; Zhong L; Wang N; Yang L; Liu CC; Li H; Wang X; Zhou Y; Zhang Y; Xu H; Bu G; Zhuang J Neuropharmacology; 2016 Sep; 108():179-92. PubMed ID: 27114256 [TBL] [Abstract][Full Text] [Related]
11. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models. Cramer PE; Cirrito JR; Wesson DW; Lee CY; Karlo JC; Zinn AE; Casali BT; Restivo JL; Goebel WD; James MJ; Brunden KR; Wilson DA; Landreth GE Science; 2012 Mar; 335(6075):1503-6. PubMed ID: 22323736 [TBL] [Abstract][Full Text] [Related]
12. Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis. Terwel D; Steffensen KR; Verghese PB; Kummer MP; Gustafsson JÅ; Holtzman DM; Heneka MT J Neurosci; 2011 May; 31(19):7049-59. PubMed ID: 21562267 [TBL] [Abstract][Full Text] [Related]
13. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide. Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180 [TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330 [TBL] [Abstract][Full Text] [Related]
15. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia. Chernick D; Ortiz-Valle S; Jeong A; Swaminathan SK; Kandimalla KK; Rebeck GW; Li L J Neurochem; 2018 Dec; 147(5):647-662. PubMed ID: 30028014 [TBL] [Abstract][Full Text] [Related]
17. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601 [TBL] [Abstract][Full Text] [Related]
18. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance. Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076 [TBL] [Abstract][Full Text] [Related]
19. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro. Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806 [TBL] [Abstract][Full Text] [Related]